Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers

Dr. Benjamin Djulbegovic, MD

Accepting New Patients

(No ratings)

Specializes in: Adult Oncology and Adult Hematology

Professional interests include: neutropenia, antiphospholipid antibody syndrome, idiopathic thrombocytopenic purpura (ITP), and more.

86 Jonathan Lucas Benign Hem Hcc2
Charleston, SC 29425

(843) 792-9300

Dr. Benjamin Djulbegovic, MD is an oncologist in DUARTE, CA specializing in adult oncology and adult hematology. Dr. Benjamin Djulbegovic, MD is affiliated with MUSC Health and UNIVERSITY MEDICAL ASSOCIATES OF THE MEDICAL UNIVERSITY OF SOUTH CAROL.

Office Locations

1500 EAST DUARTE ROAD
DUARTE, CA 91010

open_in_new

2575 Elms Center Road Suite 100
North Charleston, SC 29406

open_in_new

MUSC Health

86 Jonathan Lucas Benign Hem Hcc2
Charleston, SC 29425

(843) 792-9300

open_in_new

Some issues Dr. Benjamin Djulbegovic, MD can help you with:

Hemophilia

Hemophilia is a bleeding disorder in which blood cannot clot normally. After an injury, people who have hemophilia bleed longer because they lack certain blood proteins that are responsible for clotting, called clotting factors. Some hemophiliacs are mildly deficient in this protein, so they bleed only when injured or after surgery. Those who are severely deficient, however, may experience symptoms of spontaneous bleeding, including the following:

Presence of blood in stool or urine
Frequent nosebleeds or large bruises
Unusual bleeding after being vaccinated
Pain, swelling, or tightness in joint

Most people with hemophilia have a family history of the disorder, though about 30% do not. The most common forms are hemophilia A (classic hemophilia) and hemophilia B (Christmas disease). Hemophilia A and B share certain characteristics, but different genes are involved. Acquired hemophilia is very rare and has been linked to autoimmune conditions, cancer, and multiple sclerosis.

Hemophilia may be diagnosed using a blood test. If there is family history of the disorder, testing may be done prenatally. Treatment involves regular intravenous replacement of clotting factors, which may be produced in a laboratory (recombinant) or come from blood donors. For people with milder forms of the disease, a hormone called desmopressin may stimulate the body to produce clotting factors. Other drug therapies include medications that help slow the breakdown of blood clots and medications that are applied directly to the wound to promote clotting.

Living with hemophilia can be challenging, but simple things may help prevent excessive bleeding. For example, choosing activities like walking or swimming over contact sports can prevent injuries and strengthen muscles while protecting the joints. Chances for bleeding may also be reduced by making sure that children wear helmets and elbow pads during activities like bicycle rides.

Platelet Disorders

Platelet disorders are conditions caused by abnormally low or high levels of platelets in the blood, or by platelets that do not function correctly. Platelets are small blood cells that help stop bleeding by clumping together and forming blood clots, allowing the body to heal.

Thrombocytopenia is a disorder where people have too few platelets. With too few platelets in the bloodstream, the blood is unable to properly clot. People with thrombocytopenia may experience prolonged external and internal bleeding. Large purple bruises (ecchymoses) and small red skin spots (petechiae) in the skin and mouth are common in those with thrombocytopenia. Other symptoms of the disorder include bleeding gums, blood in bodily fluids, and fatigue. Thrombocytopenia most often arises from a different condition or treatment, such as alcoholism, autoimmune disease, cancer treatments, viruses (such as Hepatitis C and HIV), bone marrow diseases (such as leukemia and aplastic anemia), enlarged spleen, and exposure to toxic chemicals. In rare cases, thrombocytopenia is inherited.

Thrombocytosis is a disorder where people have too high of a concentration of platelets. Excess platelets can cause blood to clot in the veins. Blood clots in the veins are particularly dangerous, as they can obstruct blood flow and cause heart attacks and strokes. Thrombocytosis has two forms:

Thrombocythemia, also referred to as primary or essential thrombosis (ET), develops from irregular bone marrow cells that produce too many platelets. The cause of these bone marrow cells is unknown.
Reactive thrombosis (RT), also referred to as secondary thrombosis, arises from a different condition such as cancer, anemia, spleen removal, or infection. It is most common in older adults, but can occur in people of all ages. Symptoms of reactive thrombosis may gradually develop over time and typically include bruising, gum bleeding, and blood clotting.
Dysfunctional platelets are unable to perform the clotting function in the blood. People with dysfunctional platelets may have normal or low platelet counts. Causes of dysfunctional platelets include autoimmune disorders, hemolysis, infections, blood and bone marrow problems, and liver or kidney conditions.

If a doctor suspects a patient has a platelet disorder, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Platelet disorders can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights. Tests measuring prothrombin time (PT), or how long it takes for blood to clot, can also detect dysfunctional platelets. If platelets do not coagulate within a certain time frame, the patient most likely has dysfunctional platelets.

Treatments for low platelet counts include steroids like Prednisone, that can assist with platelet production. If a patient's low platelet count is caused by spleen problems, spleen removal (splenectomy) may be recommended. To treat the prolonged bleeding caused by thrombocytopenia, doctors frequently prescribe Dempressin, a hormone that promotes blood clotting. Antifibrinolytic medications such as tranexamic acid may also aid in the promotion of clotting and the prevention of bleeding. For patients with severe platelet disorders (either low platelet count and dysfunctional platelets), blood transfusions may be prescribed. Platelet blood transfusions deliver donated platelets to patients intravenously, replenishing the volume of functioning platelets.

Patients with high platelet counts are frequently prescribed a daily dose of over-the-counter medication aspirin. Platelet-lowering medications, such as hydroxyurea and Intron A, may reduce the likelihood of blood clot formation. Excess platelets may also be removed from the blood by a procedure called plateletpheresis or platelet reduction apheresis, where blood is drawn, circulated into a centrifuge that separates the blood components, and returned to the body with some platelets extracted. Plateletpheresis is a rare procedure reserved for patients who have severe clotting.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Patients with high blood count are advised to drink plenty of water, exercise regularly, and to avoid smoking. Many people with platelet disorders can live healthy and fulfilling lives with proper treatment and precautions.

Thrombocytopenia (Low Platelet Count)

If a doctor suspects a patient has a thrombocytopenia, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Thrombocytopenia can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Many people with thrombocytopenia can live healthy and fulfilling lives with proper treatment and precautions.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Benjamin Djulbegovic, MD treated as an oncologist in DUARTE, CA during 2012 were hospital care and inpatient care.

Volume of procedures performed by Dr. Benjamin Djulbegovic, MD for Medicare patients.

doctor visit	123
hospital care	124
inpatient care	124

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Benjamin Djulbegovic, MD treated as an oncologist in DUARTE, CA during 2013 were hospital care and inpatient care.

Volume of procedures performed by Dr. Benjamin Djulbegovic, MD for Medicare patients.

doctor visit	171
hospital care	235
inpatient care	235

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Benjamin Djulbegovic, MD.

**Gender**
Male	83
Female	63

**Ethnicity**
Non-Hispanic White	106
Black	22
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	68
From 75 to 84	0
85 and over	0
Less than 65	36

Conditions of Medicare patients treated by Dr. Benjamin Djulbegovic, MD in 2013

Hypertension	74
High Cholesterol	57
Stroke	12
Ischemic Heart Disease	52
Depression	24
Chronic Kidney Disease	41
Asthma	12
Osteoperosis	0
Atrial Fibrilation	20
Heart Failure	31
Chronic Obstructive Pulmonary Disease	25
Diabetes	31
Dementia	0
Cancer	25

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Benjamin Djulbegovic, MD treated as an oncologist in DUARTE, CA during 2014 were hospital care and inpatient care.

Volume of procedures performed by Dr. Benjamin Djulbegovic, MD for Medicare patients.

doctor visit	139
hospital care	85
inpatient care	85

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Benjamin Djulbegovic, MD.

**Gender**
Male	47
Female	43

**Ethnicity**
Non-Hispanic White	65
Black	13
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	44
From 75 to 84	21
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Benjamin Djulbegovic, MD in 2014

Hypertension	68
High Cholesterol	52
Stroke	0
Ischemic Heart Disease	48
Depression	26
Chronic Kidney Disease	37
Asthma	0
Osteoperosis	0
Atrial Fibrilation	13
Heart Failure	26
Chronic Obstructive Pulmonary Disease	19
Diabetes	31
Dementia	0
Cancer	27

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Benjamin Djulbegovic, MD treated as an oncologist in DUARTE, CA during 2015 were hospital care and inpatient care.

Volume of procedures performed by Dr. Benjamin Djulbegovic, MD for Medicare patients.

doctor visit	145
hospital care	196
inpatient care	196

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Benjamin Djulbegovic, MD.

**Gender**
Male	158
Female	128

**Ethnicity**
Non-Hispanic White	174
Black	58
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	106
From 75 to 84	0
85 and over	0
Less than 65	106

Conditions of Medicare patients treated by Dr. Benjamin Djulbegovic, MD in 2015

Hypertension	73
High Cholesterol	51
Stroke	8
Ischemic Heart Disease	55
Depression	41
Chronic Kidney Disease	52
Asthma	17
Osteoperosis	0
Atrial Fibrilation	20
Heart Failure	38
Chronic Obstructive Pulmonary Disease	27
Diabetes	30
Dementia	13
Cancer	33

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Benjamin Djulbegovic, MD treated as an oncologist in DUARTE, CA during 2016 were hospital care and inpatient care.

Volume of procedures performed by Dr. Benjamin Djulbegovic, MD for Medicare patients.

doctor visit	61
hospital care	152
inpatient care	152

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Benjamin Djulbegovic, MD.

**Gender**
Male	57
Female	60

**Ethnicity**
Non-Hispanic White	76
Black	27
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	47
From 75 to 84	0
85 and over	0
Less than 65	35

Conditions of Medicare patients treated by Dr. Benjamin Djulbegovic, MD in 2016

Hypertension	75
High Cholesterol	52
Stroke	18
Ischemic Heart Disease	64
Depression	46
Chronic Kidney Disease	51
Asthma	29
Osteoperosis	12
Atrial Fibrilation	20
Heart Failure	41
Chronic Obstructive Pulmonary Disease	28
Diabetes	38
Dementia	23
Cancer	32

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Benjamin Djulbegovic, MD treated as an oncologist in DUARTE, CA during 2019 were hospital care and inpatient care.

Volume of procedures performed by Dr. Benjamin Djulbegovic, MD for Medicare patients.

hospital care	75
inpatient care	75

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Benjamin Djulbegovic, MD.

**Gender**
Male	20
Female	22

**Ethnicity**
Non-Hispanic White	28
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	23
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Benjamin Djulbegovic, MD in 2019

Hypertension	74
High Cholesterol	57
Stroke	0
Ischemic Heart Disease	43
Depression	31
Chronic Kidney Disease	52
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	31
Chronic Obstructive Pulmonary Disease	0
Diabetes	38
Dementia	0
Cancer	33

Medicare Procedure and Patient Information

Conditions of Medicare patients treated by Dr. Benjamin Djulbegovic, MD in 2020

Hypertension	75
High Cholesterol	75
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	70
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	55

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2020

Volume of procedures performed by Dr. Benjamin Djulbegovic, MD for Medicare patients.

The highest averages for the top procedures that Dr. Benjamin Djulbegovic, MD treated as an oncologist in DUARTE, CA were hospital care and inpatient care.

doctor visit	127
hospital care	144
inpatient care	144

Average Medicare Patient Data From 2012 - 2020

Information about Medicare patients treated by Dr. Benjamin Djulbegovic, MD.

**Gender**
Male	52
Female	45

**Ethnicity**
Black / African American	17
Asian / Pacific Islander	0
Non-Hispanic White	64
Hispanic	0
Native American / Alaskan Native	0
Other	0

**Age**
75 to 84	3
85 and over	0
Less than 65	25
65 to 74	41

Average of Total of Conditions of Medicare patients treated by Dr. Benjamin Djulbegovic, MD From 2012 - 2020

The highest averages of the most common conditions of Medicare patients that Dr. Benjamin Djulbegovic, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	62
High Cholesterol	49
Stroke	5
Ischemic Heart Disease	37
Depression	24
Chronic Kidney Disease	43
Asthma	8
Osteoporosis	1
Heart Failure	23
Chronic Obstructive Pulmonary Disease	14
Diabetes	24
Atrial Fibrillation	10
Cancer	29
Dementia	5

Education & Training

He completed residency at University of Louisville Affiliated Hospitals. He is certified by the American Board of Internal Medicine: Hematology and has a state license in South Carolina.

Residency: University of Louisville Affiliated Hospitals

Board Certification: American Board of Internal Medicine: Hematology

Licensed In: South Carolina

Affiliations & Hospitals

Dr. Benjamin Djulbegovic, MD is associated with these hospitals and organizations:

MUSC Health

UNIVERSITY MEDICAL ASSOCIATES OF THE MEDICAL UNIVERSITY OF SOUTH CAROL

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Benjamin Djulbegovic, MD appears to accept the following insurance providers: CIGNA Medicare, Aetna Medicare, Great-West Healthcare, WellCare, Community Care Network (CCN), United Healthcare, TRICARE, Employers Health Network, Medicaid, Humana, Coventry, Cigna, Blue Choice, First Health, MedCost, Molina Healthcare, Group Health Plan (GHP), Medicare A & B (Traditional Medicare), Blue Cross Blue Shield State Health Plan for South Carolina, Blue Cross Blue Shield Preferred Blue (PPC), BCBS Blue Essentials (Marketplace), Aetna (Preferred Provider Organization), Blue Cross Blue Shield Planned Administrators, First Choice/Select Health (NEIC), Absolute Total Care (NEIC), Clover Health, Blue Cross Blue Shield Medicare, Aetna (Open Choice), AllWell by Absolute Total Care, Aetna (Managed Choice), Blue Cross Blue Shield Federal (FEP), Ambetter from Absolute Total Care (Marketplace), First Choice Next and Aetna (Exclusive Choice).

Insurance Accepted by Provider includes:

According to our sources, Dr. Benjamin Djulbegovic, MD accepts the following insurance providers:

CIGNA Medicare

Aetna Medicare

Great-West Healthcare

WellCare

Community Care Network (CCN)

United Healthcare

TRICARE

Employers Health Network

Medicaid

Humana

Coventry

Cigna

Blue Choice

First Health

MedCost

Molina Healthcare

Group Health Plan (GHP)

Medicare A & B (Traditional Medicare)

Blue Cross Blue Shield State Health Plan for South Carolina

Blue Cross Blue Shield Preferred Blue (PPC)

BCBS Blue Essentials (Marketplace)

Aetna (Preferred Provider Organization)

Blue Cross Blue Shield Planned Administrators

First Choice/Select Health (NEIC)

Absolute Total Care (NEIC)

Clover Health

Blue Cross Blue Shield Medicare

Aetna (Open Choice)

AllWell by Absolute Total Care

Aetna (Managed Choice)

Blue Cross Blue Shield Federal (FEP)

Ambetter from Absolute Total Care (Marketplace)

First Choice Next

Aetna (Exclusive Choice)

Ratings & Reviews

Dr. Benjamin Djulbegovic, MD does not have any reviews yet, be the first to leave a review of Dr. Benjamin Djulbegovic, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Benjamin Djulbegovic, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Celgene Corporation	$5,600 $5,600
UCB SA	$1,200 $1,200
Janssen Scientific Affairs, LLC	$68 IMBRUVICA $68
Grifols USA, LLC	$51 Alphanate $51
Jazz Pharmaceuticals Inc.	$29 RYLAZE $29

**Types of Payments**
Consulting Fee	$6,800
Food and Beverage	$96
Education	$51

Research Payments

Dr. Benjamin Djulbegovic, MD has received 3 research payments totaling $664,244.

Biography

Dr. Benjamin Djulbegovic is a specialist in adult hematology and adult oncology. Dr. Djulbegovic's areas of expertise include idiopathic thrombocytopenic purpura (ITP), leukopenia, and hemolytic anemia. He appears to be an in-network provider for Blue California, Coventry, Employers Health Network, and more. He trained at a hospital affiliated with the University of Louisville for his residency. He is affiliated with MUSC Health. According to Doctor.com, he is currently accepting new patients at his office in DUARTE, CA.